rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Andrew Enrietti

Officer

Company insider

Files Form 4 as: Officer, Viatris.

Every Form 4 they filed

In numbers

Trades disclosed
59
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
15 Aug 2025
Last trade
15 Aug 2026
Last filed
18 Aug 2026

Companies traded

Where they are an officer
VTRS ViatrisOfficer · Pharmaceuticals · last 15 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code M—25,134 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$177K10,931 at $16.23filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code M—999 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—25,134 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—998.36 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$7,060435 at $16.23filing
15 Aug 2026filed 18 Aug 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—25,134 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code M—998.364 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code M—25,134 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$177K10,931 at $16.23filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code M—999 at $0.00filing
15 Aug 2026filed 18 Aug 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$7,060435 at $16.23filing
6 Mar 2026filed 10 Mar 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code X—19,169 at $0.00filing
6 Mar 2026filed 10 Mar 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$118K8,337 at $14.16filing
6 Mar 2026filed 10 Mar 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code X—952 at $0.00filing
6 Mar 2026filed 10 Mar 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code X—19,169 at $0.00filing
6 Mar 2026filed 10 Mar 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code X—951.62 at $0.00filing
6 Mar 2026filed 10 Mar 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code A—60,435 at $0.00filing
6 Mar 2026filed 10 Mar 2026VTRS ViatrisPharmaceuticalsSEC FORM 4 Code F$5,876415 at $14.16filing
6 Mar 2026filed 10 Mar 2026VTRS Viatrisoption or derivative · PharmaceuticalsSEC FORM 4 Code X—19,169 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

David S. SimmonsDirector · Director at Viatris, filing Form 4 there in the last year
Leo Frans GroothuisDirector · Director at Viatris, filing Form 4 there in the last year
Paul CampbellOfficer · Officer at Viatris, filing Form 4 there in the last year
Corinne Le GoffChief Commercial Officer · Chief Commercial Officer at Viatris, filing Form 4 there in the last year
Elisha W. FinneyDirector · Director at Viatris, filing Form 4 there in the last year